date,title,source
Oct-18-18,Intellia Therapeutics Presents New Data in In Vivo and Ex Vivo Programs at the 26th Annual Congress of the European Society of Gene and Cell Therapy,GlobeNewswire
Oct-29-18,Intellia Therapeutics Names Glenn Goddard as New Chief Financial Officer,GlobeNewswire
Oct-31-18,Edited Transcript of NTLA earnings conference call or presentation 31-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-31-18,Cambridge's Intellia delays gene editing trial,American City Business Journals
Oct-31-18,"Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-01-18,Edited Transcript of NTLA earnings conference call or presentation 31-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-05-18,Here's Why CRISPR Stocks Fell as Much as 40.7% in October,Motley Fool
Nov-05-18,Edited Transcript of NTLA earnings conference call or presentation 31-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-06-18,Edited Transcript of NTLA earnings conference call or presentation 31-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-07-18,Cambridge's Editas asks FDA to start gene editing trial,American City Business Journals
Nov-07-18,Edited Transcript of NTLA earnings conference call or presentation 31-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-07-18,"Consolidated Research: 2018 Summary Expectations for STORE Capital, Ares Commercial Real Estate, Intellia Therapeutics, City Office REIT, RealPage, and Data I/O  Fundamental Analysis, Key Performance Indications",GlobeNewswire
